Troglitazone prevents the inhibitory effects of inflammatory cytokines on insulin-induced adipocyte differentiation in 3T3-L1 cells.

No abstract is available for this paper.

• Publication year

  1994

• Venue

  Endocrinology

• Publication date

  1994-11-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1210/ENDO.135.5.7956951PMID 7956951
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Altered gene expression for tumor necrosis factor-alpha and its receptors during drug and dietary modulation of insulin resistance.

  1994cited by this paper
• Troglitazone Prevents Glucose-Induced Insulin Resistance of Insulin Receptor in Rat-1 Fibroblasts

  1994cited by this paper
• Lipoprotein lipase gene expression: physiological regulators at the transcriptional and post-transcriptional level.

  1993cited by this paper
• Tumor necrosis factor-alpha suppresses insulin-induced tyrosine phosphorylation of insulin receptor and its substrates.

  1993cited by this paper
• Evidence for the involvement of interleukin 6 in experimental cancer cachexia.

  1992cited by this paper
• Antisense CCAAT/enhancer-binding protein RNA suppresses coordinate gene expression and triglyceride accumulation during differentiation of 3T3-L1 preadipocytes.

  1992cited by this paper
• Interleukin-6 and its receptor: a paradigm for cytokines.

  1992cited by this paper
• Tumor necrosis factor-induced reversal of adipocytic phenotype of 3T3-L1 cells is preceded by a loss of nuclear CCAAT/enhancer binding protein (C/EBP).

  1992cited by this paper
• Tumor necrosis factor impairs insulin action on peripheral glucose disposal and hepatic glucose output.

  1992cited by this paper
• Enhancement of adipocyte differentiation by an insulin-sensitizing agent.

  1992cited by this paper
• CCAAT-enhancer binding protein: a component of a differentiation switch.

  1991cited by this paper
• Serum interleukin-6 concentrations are elevated and associated with elevated tumor necrosis factor-alpha and immunoglobulin G and A concentrations in children with HIV infection.

  1991cited by this paper
• The CCAAT/enhancer binding protein and its role in adipocyte differentiation: evidence for direct involvement in terminal adipocyte development.

  1991cited by this paper
• Antidiabetic AD4743 enhances adipocyte differentiation of 3T3 T mesenchymal stem cells

  1991cited by this paper
• Cloning and expression of cDNAs for two distinct murine tumor necrosis factor receptors demonstrate one receptor is species specific.

  1991cited by this paper
• The metabolic effects of tumor necrosis factor and other cytokines

  1991cited by this paper
• Transforming growth factor beta 1 induces cachexia and systemic fibrosis without an antitumor effect in nude mice.

  1991cited by this paper
• Transcriptional repression of the GLUT4 and C/EBP genes in 3T3-L1 adipocytes by tumor necrosis factor-alpha.

  1991cited by this paper
• Fatal syndrome in mice engrafted with cells producing high levels of the leukemia inhibitory factor.

  1989cited by this paper
• Sequence, tissue distribution, and differential expression of mRNA for a putative insulin-responsive glucose transporter in mouse 3T3-L1 adipocytes.

  1989cited by this paper
• Elevated levels of circulating cachectin/tumor necrosis factor in patients with acquired immunodeficiency syndrome.

  1988cited by this paper
• Isolation of a recombinant copy of the gene encoding C/EBP.

  1988cited by this paper
• Preadipocyte differentiation in vitro: Identification of a highly active adipogenic agent

  1988cited by this paper
• Characterization of New Oral Antidiabetic Agent CS-045: Studies in KK and ob/ob Mice and Zucker Fatty Rats

  1988cited by this paper
• Raised serum levels of tumour necrosis factor in parasitic infections.

  1986cited by this paper
• Evidence for the involvement of vicinal sulfhydryl groups in insulin-activated hexose transport by 3T3-L1 adipocytes.

  1985cited by this paper
• Phorbol esters modulate insulin receptor phosphorylation and insulin action in cultured hepatoma cells.

  1984cited by this paper
• Isolation of biologically active ribonucleic acid from sources enriched in ribonuclease.

  1979cited by this paper
• Cachexia, the metabolic component of neoplastic diseases.

  1977cited by this paper

• Beyond inflammation: the multifaceted therapeutic potential of targeting the CXCL8-CXCR1/2 axis in type 1 diabetes

  2025cites this paper
• The transcription factor Foxp1 regulates aerobic glycolysis in adipocytes and myocytes

  2023cites this paper
• LSU Digital Commons LSU Digital Commons Regulation of adipose tissue metabolism by NFkB P65 in Regulation of adipose tissue metabolism by NFkB P65 in transgenic mice transgenic mice

  2022cites this paper
• Farrerol Induces Cancer Cell Death via ERK Activation in SKOV3 Cells and Attenuates TNF-α-Mediated Lipolysis

  2021cites this paper
• FOXK1 and FOXK2 regulate aerobic glycolysis

  2019cites this paper
• Cytokines and inflammation in adipogenesis: an updated review

  2019cites this paper
• Inflammatory Markers in Anorexia Nervosa: An Exploratory Study

  2018cites this paper
• Collaborative Power of Nrf2 and PPARγ Activators against Metabolic and Drug-Induced Oxidative Injury

  2017cites this paper
• Hypoglycaemic activity of 2-dodecyl-6-methoxycyclohexa-2,5-diene-1,4-dione in streptozotocin-induced diabetic mice through ameliorating metabolic function and regulating peroxisome proliferator-activated receptor γ

  2016cites this paper
• Impact of TNF and IL-1β on capillary networks within engineered human adipose tissues.

  2016cites this paper
• IL-1 family members in the pathogenesis and treatment of metabolic disease: Focus on adipose tissue inflammation and insulin resistance.

  2015cites this paper
• Metabolic and immune system cross-talk in human adipose tissue

  2014cites this paper
• Treatment of metabolic syndrome with ankaflavin, a secondary metabolite isolated from the edible fungus Monascus spp.

  2014cites this paper
• Thiazolidinedione-induced activation of the transcription factor peroxisome proliferator-activated receptor γ in cells adjacent to the murine skeletal muscle: implications for fibroblast functions

  2014cites this paper
• Impaired Adipogenesis and Insulin Resistance in Epicardial Fat‐Mesenchymal Cells From Patients With Cardiovascular Disease

  2014cites this paper
• Monascin improves diabetes and dyslipidemia by regulating PPARγ and inhibiting lipogenesis in fructose-rich diet-induced C57BL/6 mice.

  2013cites this paper
• Ankaflavin regulates adipocyte function and attenuates hyperglycemia caused by high-fat diet via PPAR-γ activation

  2013cites this paper
• Angelica keiskei Extract Improves Insulin Resistance and Hypertriglyceridemia in Rats Fed a High-Fructose Drink

  2012cites this paper
• Efficacy and Safety of Ashitaba (Angelica keiskei) on the Patients and Candidates with Metabolic Syndrome: A Pilot Study

  2012cites this paper
• Six New Chalcones from Angelica keiskei Inducing Adiponectin Production in 3T3-L1 Adipocytes

  2012cites this paper
• Molecular Biology of Steroid and Nuclear Hormone Receptors

  2012cites this paper
• Osteobiology of Aging

  2011cites this paper
• MIF Expression in Induced Peripheral Blood Mononuclear Cells by Vitamin D3 and its Potential Correlation with Resting Metabolic Rate in Obesity

  2011cites this paper
• Engineering of Adipose Tissue

  2011cites this paper
• The Monascus metabolite monascin against TNF-α-induced insulin resistance via suppressing PPAR-γ phosphorylation in C2C12 myotubes.

  2011cites this paper
• Rosiglitazone increases cell surface GLUT4 levels in 3T3-L1 adipocytes through an enhancement of endosomal recycling.

  2010cites this paper
• Serum Osteoprotegerin, a Potential Novel Marker of Systemic Inflammation: The Influence of Obesity, Insulin Sensitivity and Oral Glucose Loading on its Circulating Concentrations

  2010cites this paper
• Homeostasis, and Obesity IL-17 Regulates Adipogenesis, Glucose

  2010cites this paper
• Visfatin regulates genes related to lipid metabolism in porcine adipocytes.

  2010cites this paper
• IL-17 Regulates Adipogenesis, Glucose Homeostasis, and Obesity

  2010cites this paper
• Pig large tumor suppressor 2 (Lats2), a novel gene that may regulate the fat reduction in adipocyte.

  2010cites this paper
• REGULATION OF ADIPOSE TISSUE METABOLISM BY NFKB P 65 IN TRANSGENIC MICE

  2009cites this paper
• Keratinocyte-derived Chemokine in Obesity

  2009cites this paper
• Regulation of adipose tissue metabolism by NFkB P65 in transgenic mice

  2009cites this paper
• On the importance of fat cell size, location and signaling in insulin resistance

  2009cites this paper
• Propolis enhances adipocyte differentiation and prevents insulin resistance in 3T3-L1 cells (propolis improves insulin resistance in vitro).

  2009cites this paper
• Leptin inhibits rosiglitazone-induced adipogenesis in murine primary adipocytes.

  2008cites this paper
• Zymosan-induced inflammation stimulates neo-adipogenesis

  2008cites this paper
• TNF-alpha and adipocyte biology.

  2008cites this paper
• TNF‐α and adipocyte biology

  2008cites this paper
• Knockdown of macrophage migration inhibitory factor disrupts adipogenesis in 3T3-L1 cells.

  2008cites this paper
• The antiadipogenic effect of macrophage-conditioned medium depends on ERK1/2 activation.

  2008cites this paper
• Autologous in vivo adipose tissue engineering in hyaluronan-based gels--a pilot study.

  2008cites this paper
• Adrenomedullin Inhibits Adipogenesis Under Transcriptional Control of Insulin

  2007influential citation
• Oncostatin M decreases adiponectin expression and induces dedifferentiation of adipocytes by JAK3- and MEK-dependent pathways.

  2007cites this paper
• Thiazolidinediones exhibit different effects on preadipocytes isolated from rat mesenteric fat tissue and cell line 3T3‐L1 cells derived from mice

  2007cites this paper
• IL‐1 receptor antagonist in metabolic diseases: Dr Jekyll or Mr Hyde?

  2006cites this paper
• Evaluation of Safety and Efficacy of Rosiglitazone in the Treatment of HIV-Associated Lipodystrophy Syndrome

  2006cites this paper
• Studies on the regulation of preadipocyte differentiation by paracrine factors secreted from muscle cells

  2006cites this paper
• Oncostatin M Inhibits Adipogenesis through the RAS/ERK and STAT5 Signaling Pathways*

  2006cites this paper
• Effect of troglitazone on tumor necrosis factor α and transforming growth factor β expression and action in human adipocyte precursor cells in primary culture

  2006cites this paper
• Effect of troglitazone on tumor necrosis factor alpha and transforming growth factor beta expression and action in human adipocyte precursor cells in primary culture.

  2006cites this paper
• Adipogenesis: cellular and molecular aspects.

  2005cites this paper
• Reversal of nonalcoholic hepatic steatosis, hepatic insulin resistance, and hyperglycemia by moderate weight reduction in patients with type 2 diabetes.

  2005cites this paper
• The role and regulation of argininosuccinate synthase in endothelial function

  2005cites this paper
• Gender differences in association of plasma adiponectin with obesity reflect resultant insulin resistance in non‐diabetic Japanese patients with schizophrenia

  2005cites this paper
• Effects of leukemia inhibitory factor on 3T3-L1 adipocytes.

  2005cites this paper
• Cytokine-mediated modulation of leptin and adiponectin secretion during in vitro adipogenesis: evidence that tumor necrosis factor-alpha- and interleukin-1beta-treated human preadipocytes are potent leptin producers.

  2005cites this paper
• Development of multiple lipomas during treatment with rosiglitazone in a patient with HIV-associated lipoatrophy.

  2004cites this paper
• Ai1812co 1741..1749

  2004cites this paper
• Bone-constructing cells from ethmoid bone may have multilineage differentiation potential: preliminary report

  2004cites this paper
• The Role of Cytokines in the Pathogenesis of Endocrine Disease

  2004cites this paper
• Proximal tubular kidney damage and tenofovir: a role for mitochondrial toxicity?

  2004cites this paper
• Inhibition of 3T3-L1 adipocyte differentiation by 6-ethoxyzolamide: repressed peroxisome proliferator-activated receptor gamma mRNA and enhanced CCAAT/enhancer binding protein beta mRNA levels.

  2004cites this paper
• Effect of Pioglitazone on Body Fat and Intramuscular Fat Accumulation in Otsuka Long- Evans Tokushima Fatty Rats : Its Relation to the Expression of Tumor Necrosis Factor-alpha mRNA (Original)

  2003cites this paper
• Subcutanous Fat Accumulation and Thiazolidinedione Derivatives : Sex Differences and Their Relation to Glycemic Control (Original)

  2003cites this paper
• Troglitazone antagonizes tumor necrosis factor-alpha-induced reprogramming of adipocyte gene expression by inhibiting the transcriptional regulatory functions of NF-kappaB.

  2003cites this paper
• Synthesis and antihyperglycemic activity of erythrose, ribose and substituted pyrrolidine containing thiazolidinedione derivatives.

  2003cites this paper
• Identification of Bioactive Molecules by Adipogenesis Profiling of Organic Compounds* 210

  2003cites this paper
• Thiazolidinediones enhance insulin-mediated suppression of fatty acid flux in type 2 diabetes mellitus.

  2002cites this paper
• Troglitazone improves GLUT4 expression in adipose tissue in an animal model of obese type 2 diabetes mellitus.

  2002cites this paper
• Evolving pathophysiologic concepts in nonalcoholic steatohepatitis

  2002cites this paper
• Correlation between the high expression of C/EBPbeta protein in F442A cells and their relative resistance to antiadipogenic action of TCDD in comparison to 3T3-L1 cells.

  2002cites this paper
• Adipogenesis and aging: does aging make fat go MAD?

  2002cites this paper
• C-reactive protein and coronary artery disease: influence of obesity, caloric restriction and weight loss.

  2002cites this paper
• Insulin resistance, diabetes, and atherosclerosis: Thiazolidinediones as therapeutic interventions

  2002cites this paper
• The mode of action of thiazolidinediones

  2002cites this paper
• Stimulation of adipogenesis, peroxisome proliferator-activated receptor-gamma (PPARgamma), and thyrotropin receptor by PPARgamma agonist in human orbital preadipocyte fibroblasts.

  2002cites this paper
• Effects of 1,1,1-trichloro-2,2-bis(p-chlorophenyl)-ethane (p,p'-DDT) on 3T3-L1 and 3T3-F442A adipocyte differentiation.

  2002cites this paper
• Nonalcoholic steatohepatitis: what we know in the new millennium

  2002cites this paper
• Adipogenesis: forces that tip the scales.

  2002cites this paper
• The Molecular Control of Adipogenesis, with Special Reference to Lymphatic Pathology

  2002cites this paper
• Thiazolidinediones

  2002cites this paper
• Stimulation of adipogenesis, peroxisome proliferator-activated receptor-γ (PPARγ), and thyrotropin receptor by PPARγ agonist in human orbital preadipocyte fibroblasts

  2002cites this paper
• Correlation between the high expression of C/EBPβ protein in F442A cells and their relative resistance to antiadipogenic action of TCDD in comparison to 3T3‐L1 cells

  2002cites this paper
• Thiazolidinedione derivative improves fat distribution and multiple risk factors in subjects with visceral fat accumulation--double-blind placebo-controlled trial.

  2001cites this paper
• Synergistic Antiadipogenic Effects of HIV Type 1 Protease Inhibitors with Tumor Necrosis Factor α: Suppression of Extracellular Insulin Action Mediated by Extracellular Matrix-Degrading Proteases

  2001cites this paper
• Molecular design, synthesis, and hypoglycemic activity of a series of thiazolidine-2,4-diones.

  2000cites this paper
• Down-regulation by troglitazone of hepatic tumor necrosis factor-alpha and interleukin-6 mRNA expression in a murine model of non-insulin-dependent diabetes.

  2000cites this paper
• Molecular regulation of adipogenesis.

  2000cites this paper
• Adipogenesis in thyroid eye disease.

  2000cites this paper
• Troglitazone and related compounds: therapeutic potential beyond diabetes.

  2000cites this paper
• PPAR agonists as direct modulators of the vessel wall in cardiovascular disease

  2000cites this paper
• The role of TNF alpha in adipocyte metabolism.

  1999cites this paper
• Effect of troglitazone on body fat distribution in type 2 diabetic patients.

  1999cites this paper
• Troglitazone exhibits immunomodulatory activity on the cytokine production of activated human lymphocytes.

  1999cites this paper
• The role of TNF a in adipoc

  1999cites this paper
• Inhibition of tumor necrosis factor-alpha with anti-diabetic agents.

  1999cites this paper
• Transmembrane Tumor Necrosis Factor (TNF)-α Inhibits Adipocyte Differentiation by Selectively Activating TNF Receptor 1*

  1999cites this paper
• Down regulation of peroxisome proliferator-activated receptorγ expression by inflammatory cytokines and its reversal by thiazolidinediones

  1999cites this paper